Evidence map›Paper›PMID 26270824›Full record

Observational studyPloS one2015

Recent Transmission Clustering of HIV-1 C and CRF17_BF Strains Characterized by NNRTI-Related Mutations among Newly Diagnosed Men in Central Italy.

Lavinia Fabeni, Claudia Alteri, Nicoletta Orchi, Caterina Gori, Ada Bertoli, Federica Forbici, Francesco Montella, Alfredo Pennica, Gabriella De Carli, Massimo Giuliani and 10 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Lavinia FabeniNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Claudia AlteriUniversity of Rome Tor Vergata, Rome, Italy.
Nicoletta OrchiNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Caterina GoriNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Ada BertoliUniversity of Rome Tor Vergata, Rome, Italy; University Hospital Tor Vergata, Rome, Italy.
Federica ForbiciNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Francesco MontellaS. Giovanni Addolorata Hospital, Division of Clinical Immunology, Rome, Italy.
Alfredo PennicaS.Andrea Hospital, Sapienza University of Rome, Rome, Italy.
Gabriella De CarliNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Massimo GiulianiIRCSS San Gallicano, Rome, Italy.
Fabio ContinenzaNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Carmela PinnettiNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Emanuele NicastriNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Francesca Ceccherini-SilbersteinUniversity of Rome Tor Vergata, Rome, Italy.
Claudio Maria MastroianniInfectious Diseases Unit, Sapienza University, Polo Pontino, Latina, Italy.
Enrico GirardiNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Massimo AndreoniUniversity Hospital Tor Vergata, Rome, Italy.
Andrea AntinoriNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Maria Mercedes SantoroUniversity of Rome Tor Vergata, Rome, Italy.
Carlo Federico PernoNational Institute for Infectious Diseases L. Spallanzani-IRCCS, Rome, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITUniversity of Rome Tor Vergata · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITAzienda Ospedaliera San Giovanni Addolorata · ITSan Gallicano Hospital · ITSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncreased evidence of relevant HIV-1 epidemic transmission in European countries is being reported, with an increased circulation of non-B-subtypes. Here, we present two recent HIV-1 non-B transmission clusters characterized by NNRTI-related amino-acidic mutations among newly diagnosed HIV-1 infected men, living in Rome (Central-Italy).

methodsPol and V3 sequences were available at the time of diagnosis for all individuals. Maximum-Likelihood and Bayesian phylogenetic-trees with bootstrap and Bayesian-probability supports defined transmission-clusters. HIV-1 drug-resistance and V3-tropism were also evaluated.

resultsAmong 534 new HIV-1 non-B cases, diagnosed from 2011 to 2014, in Central-Italy, 35 carried virus gathering in two distinct clusters, including 27 HIV-1 C and 8 CRF17_BF subtypes, respectively. Both clusters were centralized in Rome, and their origin was estimated to have been after 2007. All individuals within both clusters were males and 37.1% of them had been recently-infected. While C-cluster was entirely composed by Italian men-who-have-sex-with-men, with a median-age of 34 years (IQR:30-39), individuals in CRF17_BF-cluster were older, with a median-age of 51 years (IQR:48-59) and almost all reported sexual-contacts with men and women. All carried R5-tropic viruses, with evidence of atypical or resistance amino-acidic mutations related to NNRTI-drugs (K103Q in C-cluster, and K101E+E138K in CRF17_BF-cluster).

conclusionsThese two epidemiological clusters provided evidence of a strong and recent circulation of C and CRF17_BF strains in central Italy, characterized by NNRTI-related mutations among men engaging in high-risk behaviours. These findings underline the role of molecular epidemiology in identifying groups at increased risk of HIV-1 transmission, and in enhancing additional prevention efforts.

Indexed as

Evolution, MolecularMutationPhylogenyAdultBase SequenceFemaleHIV-1HIV InfectionsHumansItalyMaleMiddle AgedMolecular Sequence Data

Identifiers

PMID26270824
PMCPMC4535860
OpenAlexW1783455409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.